Showing results (71-80 of 321) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|March 9, 2005
The effect of cardiac resynchronization on morbidity and mortality in heart failureJohn G F Cleland, Jean-Claude Daubert, Erland Erdmann, et al.
Journal of the American College of Cardiology|March 3, 2012
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertensionMathias C Brandt, Felix Mahfoud, Sara Reda, et al.
Cost Effectiveness and Resource Allocation : C/E|May 7, 2009
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspectiveWerner A Scherbaum, Gordon Goodall, Katrina M Erny-Albrecht, et al.
European Journal of Heart Failure|May 4, 2012
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trialJohn G F Cleland, Nick Freemantle, Erland Erdmann, et al.
Current Heart Failure Reports|February 17, 2016
Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future PerspectiveMarcel Halbach, Thorsten Fritz, Navid Madershahian, et al.
Journal of Clinical Pathology|May 10, 2012
Usefulness of imprint and brushing cytology in diagnosis of lung diseases with flexible bronchoscopyGuido Michels, Theodoros Topalidis, Reinhard Büttner, et al.
International Heart Journal|November 10, 2017
Improvement of Left Ventricular Ejection Fraction by Baroreflex Activation Therapy in a Young Man with Dilated CardiomyopathyMarcel Halbach, Thorsten Fritz, Navid Madershahian, et al.
British Journal of Pharmacology|May 1, 2026
Cardiotoxicity of BRAF/MEK inhibitorsKatharina Seuthe, Valerie Lohner, Kevin Terre, et al.
Pageof 33